• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌产β-内酰胺酶的阿莫西林耐药性。

Amoxicillin resistance with beta-lactamase production in Helicobacter pylori.

机构信息

Department of Microbiology, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Eur J Clin Invest. 2009 Sep;39(9):807-12. doi: 10.1111/j.1365-2362.2009.02166.x. Epub 2009 Jul 17.

DOI:10.1111/j.1365-2362.2009.02166.x
PMID:19614952
Abstract

BACKGROUND

Amoxicillin-resistant Helicobacter pylori with minimal inhibitory concentration (MIC) >or= 256 mg L(-1) was isolated from a gastritis patient. The aims were to investigate the mechanism of high-level amoxicillin resistance in H. pylori.

MATERIALS AND METHODS

The beta-lactamase production was determined by means of nitrocefin sticks and the presence of gene encoding the beta-lactam antibiotic resistance enzyme TEM beta-lactamase was analysed by polymerase chain reaction (PCR), sequencing and dot-blot hybridization. Sequencing analysis of pbp1A gene was performed and amoxicillin-susceptible isolate was transformed with pbp1A PCR products from the resistant isolate. The expression of hefC efflux system was analysed using real-time quantitative PCR.

RESULTS

Activity of beta-lactamase was detected. Sequence analysis showed that the PCR product derived from H. pylori 3778 was identical to the bla(TEM-1) (GenBank accession EU726527). Dot-blot hybridization confirmed the presence of beta-lactamase gene bla(TEM-1.) By transformation of PCR product of mutated pbp1A gene from H. pylori 3778 into amoxicillin-susceptible strain showed that substitutions in Thr(556)-->Ser, Lys(648)-->Gln, Arg(649)-->Lys and Arg(656)-->Pro contribute to low-level amoxicillin resistance. The MIC of amoxicillin for the transformants was 0.75 mg L(-1). Over-expression of hefC was not found.

CONCLUSIONS

High-level amoxicillin resistance is associated with beta-lactamase production in H. pylori. Low-level amoxicillin resistance is linked to a point mutation on pbp1A. Because H. pylori can exchange DNA through natural transformation, spreading of bla(TEM-1) amoxicillin resistance gene among H. pylori is a potential threat when treating H. pylori infection.

摘要

背景

从一位胃炎患者中分离出对最小抑菌浓度(MIC)≥256 毫克/升的阿莫西林耐药幽门螺杆菌。目的是研究幽门螺杆菌高水平阿莫西林耐药的机制。

材料与方法

采用硝基头孢菌素棒法检测β-内酰胺酶的产生,并通过聚合酶链反应(PCR)、测序和点印迹杂交分析编码β-内酰胺抗生素耐药酶 TEM β-内酰胺酶的基因。对 pbp1A 基因进行测序分析,并将耐药分离株的 pbp1A PCR 产物转化为阿莫西林敏感分离株。使用实时定量 PCR 分析 hefC 外排系统的表达。

结果

检测到β-内酰胺酶的活性。序列分析表明,从幽门螺杆菌 3778 中获得的 PCR 产物与 bla(TEM-1)(GenBank 登录号 EU726527)完全相同。点印迹杂交证实存在 bla(TEM-1)β-内酰胺酶基因。将突变的 pbp1A 基因的 PCR 产物从幽门螺杆菌 3778 转化为阿莫西林敏感株表明,Thr(556)→Ser、Lys(648)→Gln、Arg(649)→Lys 和 Arg(656)→Pro 的取代导致低水平阿莫西林耐药。转化子的阿莫西林 MIC 为 0.75 毫克/升。未发现 hefC 的过度表达。

结论

幽门螺杆菌中产β-内酰胺酶与高水平阿莫西林耐药有关。低水平阿莫西林耐药与 pbp1A 上的点突变有关。由于幽门螺杆菌可以通过自然转化交换 DNA,因此在治疗幽门螺杆菌感染时,bla(TEM-1)阿莫西林耐药基因在幽门螺杆菌中的传播是一个潜在的威胁。

相似文献

1
Amoxicillin resistance with beta-lactamase production in Helicobacter pylori.幽门螺杆菌产β-内酰胺酶的阿莫西林耐药性。
Eur J Clin Invest. 2009 Sep;39(9):807-12. doi: 10.1111/j.1365-2362.2009.02166.x. Epub 2009 Jul 17.
2
Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori.青霉素结合蛋白1A保守的青霉素结合蛋白基序内或其附近的多个突变赋予幽门螺杆菌对阿莫西林的耐药性。
Helicobacter. 2006 Jun;11(3):181-7. doi: 10.1111/j.1523-5378.2006.00398.x.
3
Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates.由于等基因分离株中PBP-1A的点突变导致幽门螺杆菌对阿莫西林产生异质性耐药。
J Antimicrob Chemother. 2008 Mar;61(3):474-7. doi: 10.1093/jac/dkm504. Epub 2008 Jan 11.
4
Differentially expressed genes in response to amoxicillin in Helicobacter pylori analyzed by RNA arbitrarily primed PCR.通过RNA任意引物PCR分析幽门螺杆菌中对阿莫西林产生反应的差异表达基因。
FEMS Immunol Med Microbiol. 2007 Jul;50(2):226-30. doi: 10.1111/j.1574-695X.2006.00209.x.
5
Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients.韩国患者分离出的幽门螺杆菌的一级和二级抗菌药物最低抑菌浓度比较。
Int J Antimicrob Agents. 2006 Jul;28(1):6-13. doi: 10.1016/j.ijantimicag.2006.02.015. Epub 2006 Jun 5.
6
Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.对抑制剂敏感的TEMβ-内酰胺酶的过度产生是粘质沙雷氏菌对β-内酰胺-β-内酰胺酶抑制剂组合耐药的原因。
Chemotherapy. 2008;54(1):31-7. doi: 10.1159/000112315. Epub 2007 Dec 7.
7
High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.从西班牙儿童中分离出的幽门螺杆菌临床菌株对克拉霉素和甲硝唑的耐药率很高。
Rev Esp Quimioter. 2009 Jun;22(2):88-92.
8
Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.台湾东部幽门螺杆菌分离株的抗生素耐药率。
J Gastroenterol Hepatol. 2007 May;22(5):720-3. doi: 10.1111/j.1440-1746.2006.04743.x.
9
[Resistance of Haemophilus influenzae and Haemophilus parainfluenzae to beta-lactam antibiotics. Characterization of the beta-lactamases].[流感嗜血杆菌和副流感嗜血杆菌对β-内酰胺类抗生素的耐药性。β-内酰胺酶的特性]
Enferm Infecc Microbiol Clin. 1992 Jun-Jul;10(6):355-9.
10
Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.波兰儿童幽门螺杆菌对抗菌药物的原发性耐药性。
Acta Microbiol Pol. 2002;51(3):255-63.

引用本文的文献

1
Spatioseasonal Comparison of Fecal Resistome and Pathogenome of Raccoon Dogs in Korea.韩国貉粪便抗性组和病原体组的时空季节性比较
Ecohealth. 2025 Aug 9. doi: 10.1007/s10393-025-01744-8.
2
Comparison of Vonoprazan Triple Therapy, Bismuth Quadruple Therapy, and Amoxicillin Therapy for Helicobacter pylori Infection: A Systematic Review.沃克三联疗法、铋剂四联疗法和阿莫西林疗法治疗幽门螺杆菌感染的比较:一项系统评价
Cureus. 2025 Apr 28;17(4):e83142. doi: 10.7759/cureus.83142. eCollection 2025 Apr.
3
Nanomaterials: A Prospective Strategy for Biofilm-Forming Treatment.
纳米材料:一种用于生物膜形成治疗的前瞻性策略。
Int J Nanomedicine. 2025 Apr 23;20:5209-5229. doi: 10.2147/IJN.S512066. eCollection 2025.
4
Molecular Mechanisms of Biofilm Formation in .. 中生物膜形成的分子机制
Antibiotics (Basel). 2024 Oct 16;13(10):976. doi: 10.3390/antibiotics13100976.
5
High salt condition alters LPS synthesis and induces the emergence of drug resistance mutations in .高盐环境改变 LPS 合成并诱导 出现耐药突变。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0058724. doi: 10.1128/aac.00587-24. Epub 2024 Sep 6.
6
Antibiotic Resistance of : Mechanisms and Clinical Implications.耐药性的抗生素 : 机制和临床意义。
J Korean Med Sci. 2024 Jan 29;39(4):e44. doi: 10.3346/jkms.2024.39.e44.
7
Antimicrobial-Resistance Profile of , Obtained from Endoscopic Patients in Bahir Dar, North West Ethiopia.从埃塞俄比亚西北部巴赫达尔的内镜检查患者中分离得到的[具体对象]的抗菌药物耐药谱。 (注:原文中“of ”后面缺少具体内容,这里根据语境补充了“[具体对象]”)
Can J Infect Dis Med Microbiol. 2023 Nov 13;2023:7326288. doi: 10.1155/2023/7326288. eCollection 2023.
8
The single nucleotide polymorphisms SNPs associated with multiple therapy resistance in Colombia.在哥伦比亚与多重治疗耐药性相关的单核苷酸多态性(SNPs)
Front Microbiol. 2023 Jul 7;14:1198325. doi: 10.3389/fmicb.2023.1198325. eCollection 2023.
9
Antibiotic Resistance: Molecular Basis and Diagnostic Methods.抗生素耐药性:分子基础与诊断方法。
Int J Mol Sci. 2023 May 29;24(11):9433. doi: 10.3390/ijms24119433.
10
Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice.幽门螺杆菌的抗生素耐药性:从潜在的生物分子机制到临床实践。
J Clin Lab Anal. 2023 Apr;37(7):e24885. doi: 10.1002/jcla.24885. Epub 2023 Apr 23.